What is the peak effect time of ketorolac (Non-Steroidal Anti-Inflammatory Drug)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Peak Effect Time of Ketorolac

The peak analgesic effect of ketorolac occurs within 2 to 3 hours after administration, regardless of route (oral, intramuscular, or intravenous). 1

Pharmacokinetic Profile by Route of Administration

Oral Administration

  • Peak plasma concentrations are achieved at approximately 60 minutes after oral dosing 2
  • Peak analgesic effect occurs at 2 to 3 hours, which is later than the peak plasma concentration 1
  • Oral bioavailability is 80-100%, making it essentially equivalent to parenteral routes in terms of total drug exposure 1, 3

Intramuscular Administration

  • Peak plasma concentrations occur at 45-50 minutes after IM injection 4, 3
  • Peak analgesic effect occurs at approximately 1 to 2 hours post-injection 4, 5
  • The FDA label confirms the peak analgesic effect occurs within 2 to 3 hours across all dosing ranges 1

Intravenous Administration

  • Peak plasma effect occurs at approximately 15 minutes due to the short lag time between injection and effect 2
  • However, the peak analgesic effect still occurs at 2 to 3 hours, similar to other routes 1
  • This represents the fastest onset for plasma concentrations but not necessarily for maximal pain relief 2

Clinical Implications for Timing

For procedural pain management, ketorolac should be administered 1 to 2 hours before the anticipated painful event to achieve optimal analgesia:

  • Oral ketorolac 20 mg given 40 to 60 minutes before IUD placement reduced pain during and 10 minutes after the procedure 2
  • Intramuscular ketorolac 30 mg given 30 minutes prior to IUD placement reduced pain at 5 and 15 minutes after placement 2
  • The American College of Obstetricians and Gynecologists recommends ketorolac (20 mg oral or 30 mg IM) given 1 to 2 hours before procedures 2

Important Caveats

Duration of effect varies more than peak effect across the dosage range—larger doses provide longer-lasting analgesia rather than greater peak effect 1. The peak analgesic effect is not statistically significantly different across recommended dosage ranges, but the duration of analgesia is dose-dependent 1.

The S-enantiomer (the active form) is cleared approximately twice as fast as the R-enantiomer, with a half-life of 2.5 hours versus 5 hours, though the overall racemate half-life is 4-6 hours 1, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Clinical pharmacokinetics of ketorolac tromethamine.

Clinical pharmacokinetics, 1992

Research

Ketorolac: a parenteral nonsteroidal antiinflammatory drug.

DICP : the annals of pharmacotherapy, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.